Viewing Study NCT06074692

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 3:28 PM
Ignite Modification Date: 2026-01-25 @ 6:18 AM
Study NCT ID: NCT06074692
Status: RECRUITING
Last Update Posted: 2023-10-31
First Post: 2023-10-03
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: PARP Inhibition, Stereotactic Body Radiotherapy and Immunotherapy for Metastatic or Advanced Sarcoma (PRIMA)
Sponsor: Ruijin Hospital
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Sarcoma View
None Sarcoma,Soft Tissue View
None Sarcoma of Bone View
Keywords:

Keywords

Keyword Brief Keyword Text View
None sarcoma View
None bone and soft tissue sarcoma View
None PARP inhibitor View
None SBRT View
None checkpoint inhibitor View